Reliance Global Group signs definitive agreement to acquire 51% of post-quantum cybersecurity firm Enquantum

Reliance Global Group, Inc.

Definitive agreement to acquire 51% of Enquantum for $2.125M, payable in milestone tranches over ~10 months.
Initial 8% ownership from $166K bridge note conversion and cash-funded issuance; monthly tranches target 48%.
Final top-up from 48% to 51% paid with $125K in Reliance common stock, no cash proceeds.
Transaction aligns with Scale51; Enquantum to be first tech portfolio under EZRA International Group.
Enquantum holds patent for FPGA-based quantum-resistant encryption; closing expected within 30 days.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

Reliance Global Group, Inc. entered into Share Purchase Agreement with Enquantum Ltd. valued at $2,125,000 aggregate purchase price (effective 2026-02-05).

Action: entry
Agreement: equity purchase
Counterparty: Enquantum Ltd.
Value: $2,125,000 aggregate purchase price
Effective: 2026-02-05

Exact text from the filing

On February 5, 2026, Reliance Global Group, Inc. (the “Company”) entered into a Share Purchase Agreement (the “Share Purchase Agreement”) with Enquantum Ltd. (“Enquantum”), pursuant to which the Company has agreed to acquire, over time and subject to the satisfaction of specified milestone criteria and other conditions, an aggregate equity interest equal to 51% of Enquantum on a fully diluted basis

View on SEC.gov

308 material agreements filed in the last 30 days. Browse all material agreements →

Reliance Global Group, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-26-005906

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.